Your browser doesn't support javascript.
loading
68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases of recurrent prostate cancer after initial surgery.
Marzec, J; Becker, J; Paulsen, F; Wegener, D; Olthof, S-C; Pfannenberg, C; Schwenck, J; Bedke, J; Stenzl, A; Nikolaou, K; la Fougère, C; Zips, D; Müller, A-C.
Afiliación
  • Marzec J; Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany.
  • Becker J; Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany.
  • Paulsen F; Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany.
  • Wegener D; Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany.
  • Olthof SC; Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Pfannenberg C; Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Schwenck J; Department of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Bedke J; Cluster of Excellnence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", University of Tuebingen, Germany.
  • Stenzl A; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Nikolaou K; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • la Fougère C; Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Zips D; Department of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Müller AC; German Cancer Consortium (DKTK), Partner Site Tübingen; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Acta Oncol ; 59(2): 149-156, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31559880
ABSTRACT

Background:

We evaluated efficacy and toxicity of 68Ga-PSMA-Positron Emission Tomography/Computed Tomography (PET/CT)-directed stereotactic body radiotherapy and image-guided radiotherapy (SBRT/IGRT) for oligometastases of prostate cancer recurrences after previous surgery.

Methods:

Nineteen patients were analyzed within a prospective PET-registry study (064/2013BO1) and retrospectively analyzed (807/2017BO2) fulfilling the following inclusion criteria biochemical recurrence after radical prostatectomy, ≤five 68Ga-PSMA-PET/CT positive lesions. Biochemical control was evaluated with EORTC (European Organization for Research and Treatment of Cancer)- and Phenix-definitions. Toxicity was scored according to CTCAE-criteria v. 4.03.

Results:

A total of 38 oligometastases (19 patients, 2 with re-treatment) were treated with SBRT/IGRT from October 2014 to July 2017. 68Ga-PSMA-PET/CT-positive lesions were detected on average 39 months (5-139) after prostatectomy (pT2b-3b pN0-1 cM0). Mean PSA (Prostate-specific antigen)-level at time of imaging reached 2.2 ng/mL (range 0.2-10.1). PET/CT-positive lesions were treated with different fractionation schedules reaching biological equivalent doses (BED) of 116.7-230.0 Gy. Concomitant androgen deprivation therapy (ADT) was given in seven patients. After a median follow-up of 17 months (4-42) all patients were alive. Estimated 1-year PSA- control (n = 19) reached 80.8% (Phenix) and 67.5% (EORTC). A PSA-decline (≥50%) was detected in 16/19 patients after radiotherapy. Higher graded G3+-acute toxicity did not occur. Temporary late G3-proctitis was detected in one patient.

Conclusions:

Reaching of nadir ≤0.1 or 0.2 ng/mL was associated by improved DMFS (distant metastases free survival) and could serve as a surrogate endpoint for RT of oligometastases after initial prostatectomy. Short term effects of 68Ga-PSMA-PET/CT-based ablative radiotherapy for oligometastases demonstrated an acceptable toxicity profile and favorable biochemical response.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Alemania